(Q46807019)

25 December 2017

title

Short waitlist time does not adversely impact outcome following liver transplantation for hepatocellular carcinoma (English)

1 reference

25 December 2017

main subject

liver transplantation

1 reference

Chao SD

1

1 reference

25 December 2017

Roberts JP

series ordinal

2

1 reference

25 December 2017

Farr M

series ordinal

3

1 reference

25 December 2017

Yao FY

series ordinal

4

1 reference

25 December 2017

language of work or name

English

0 references

publication date

8 April 2007

1 reference

25 December 2017

American Journal of Transplantation

published in

1 reference

25 December 2017

volume

7

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

1594-1600

1 reference

25 December 2017

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Liver transplantation for hepatocellular carcinoma: the MELD impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Role of adult living liver donation in patients with hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Living donor liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Adult-to-adult transplantation of the right hepatic lobe from a living donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Selection criteria for liver transplantation in patients with hepatocellular carcinoma: beyond tumor size and number?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01800.X

10.1111/J.1600-6143.2007.01800.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017